Chronic lymphocytic leukemia.

Chiorazzi, Nicholas; Rai, Kanti R.; Ferrarini, Manlio

doi:10.1056/nejmra041720

Cited by 1,296

The DOI matches its Crossref record.

Chronic lymphocytic leukemia.

Chiorazzi, Nicholas, Rai, Kanti R., Ferrarini, Manlio·2005·New England Journal of Medicine

DOI 10.1056/nejmra041720

Open this paper in CoChat — free account

Abstract

Our concept of the pathogenesis of chronic lymphocytic leukemia has undergone remarkable changes during the past decade. This review addresses the latest ideas concerning the origin of this common form of leukemia and discusses how molecular investigations are beginning to change the management of the disease.

Integrity signals

Registry

Crossref · 10.1056/nejmra041720

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

No references could be resolved yet.

Research works printed but not linked: 112

10.1056/NEJM199510193331606 · DOI
Dameshek W, 1967, Blood, 29, 566, 10.1182/blood.V29.4.566.566 · DOI
Patel DV, Rai KR. Chronic lymphocytic leukemia. In: Hoffman R, Benz EJ, Shattil SJ, et al., eds. Hematology, principles and practice. 4th ed. Philadelphia: Elsevier Churchill Livingstone, 2005:1437-54.
10.1084/jem.180.1.5 · DOI
10.1084/jem.191.3.485 · DOI
10.1006/clim.2001.5049 · DOI
10.1073/pnas.98.3.1166 · DOI
10.1084/jem.20011112 · DOI
10.1126/science.1073924 · DOI
Deaglio S, 1998, J Immunol, 160, 395, 10.4049/jimmunol.160.1.395 · DOI
Lund FE, 1996, J Immunol, 157, 1455, 10.4049/jimmunol.157.4.1455 · DOI
Zupo S, 2000, Blood, 95, 1199, 10.1182/blood.V95.4.1199.004k21_1199_1206 · DOI
10.1038/nri955 · DOI
10.1016/0092-8674(92)90598-7 · DOI
Matutes E, 1994, Leukemia, 8, 1640
Moreau EJ, 1997, Am J Clin Pathol, 108, 378, 10.1093/ajcp/108.4.378 · DOI
Ternynck T, 1974, Blood, 43, 789, 10.1182/blood.V43.6.789.789 · DOI
Rai KR, 1975, Blood, 46, 219, 10.1182/blood.V46.2.219.219 · DOI
10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V · DOI
10.1016/0167-5699(94)90009-4 · DOI
10.1084/jem.181.4.1507 · DOI
Oscier DG, 1997, Blood, 89, 4153, 10.1182/blood.V89.11.4153 · DOI
10.1172/JCI3009 · DOI
Hamblin TJ, 1999, Blood, 94, 1848, 10.1182/blood.V94.6.1848 · DOI
Krober A, 2002, Blood, 100, 1410, 10.1182/blood.V100.4.1410.h81602001410_1410_1416 · DOI
Zupo S, 1996, Blood, 88, 1365, 10.1182/blood.V88.4.1365.bloodjournal8841365 · DOI
Damle RN, 1999, Blood, 94, 1840, 10.1182/blood.V94.6.1840 · DOI
10.1182/blood.V98.1.181 · DOI
10.1046/j.1365-2141.2001.03149.x · DOI
10.1056/NEJMoa023143 · DOI · Paper page
10.1182/blood-2002-06-1683 · DOI · Paper page
10.1182/blood-2002-10-3306 · DOI
10.1016/S0140-6736(03)15260-9 · DOI · Paper page
10.1056/NEJMoa040857 · DOI · Paper page
10.1084/jem.194.11.1639 · DOI
10.1084/jem.194.11.1625 · DOI
Maloum K, 2000, Blood, 96, 377, 10.1182/blood.V96.1.377 · DOI
10.1182/blood.V99.3.1023 · DOI
Oscier DG, 2002, Blood, 100, 1177, 10.1182/blood.V100.4.1177.h81602001177_1177_1184 · DOI
10.1146/annurev.immunol.21.120601.141018 · DOI
10.1182/blood-2003-12-4312 · DOI
10.1182/blood.V97.6.1892 · DOI
10.1182/blood-2002-06-1801 · DOI
10.1016/1074-7613(95)90029-2 · DOI
10.1056/NEJM200012283432602 · DOI
10.1182/blood.V97.7.2098 · DOI
10.1073/pnas.242606799 · DOI · Paper page
10.1038/nrg1379 · DOI · Paper page
10.1073/pnas.0404432101 · DOI
10.1073/pnas.91.26.12530 · DOI
Narducci MG, 2000, Cancer Res, 60, 2095
10.1073/pnas.102181599 · DOI · Paper page
10.1182/blood-2003-10-3407 · DOI
Johnson TA, 1997, J Immunol, 158, 235, 10.4049/jimmunol.158.1.235 · DOI
Widhopf GF II, 2001, J Immunol, 166, 95, 10.4049/jimmunol.166.1.95 · DOI
10.1182/blood-2002-08-2432 · DOI
10.1182/blood.V99.6.2262 · DOI
10.1182/blood-2002-11-3485 · DOI
10.1172/JCI19399 · DOI
10.1084/jem.20040544 · DOI
10.1182/blood-2004-01-0132 · DOI
10.1182/blood-2004-03-0818 · DOI
10.1016/0896-8411(88)90068-6 · DOI
10.1084/jem.169.1.255 · DOI
Borche L, 1990, Blood, 76, 562, 10.1182/blood.V76.3.562.562 · DOI
10.1016/0167-5699(94)90022-1 · DOI
Diaw L, 1997, J Immunol, 158, 968, 10.4049/jimmunol.158.2.968 · DOI
10.1016/S0167-5699(99)01509-1 · DOI
10.1093/intimm/3.9.865 · DOI
Dameshek W, 1959, Blood, 14, 1151, 10.1182/blood.V14.10.1151.1151 · DOI
10.1038/ni1036 · DOI
10.1016/j.coi.2004.03.010 · DOI
10.1002/eji.1830160821 · DOI
Karray S, 1987, Blood, 70, 1105, 10.1182/blood.V70.4.1105.1105 · DOI
Michel F, 1993, J Immunol, 150, 3624, 10.4049/jimmunol.150.8.3624 · DOI
Lankester AC, 1995, Blood, 86, 1090, 10.1182/blood.V86.3.1090.1090 · DOI
10.1182/blood-2001-11-0126 · DOI
10.1182/blood-2002-06-1822 · DOI
10.1046/j.1365-2141.2002.03759.x · DOI
10.1038/sj.leu.2402944 · DOI
Alfarano A, 1999, Blood, 93, 2327, 10.1182/blood.V93.7.2327 · DOI
10.1073/pnas.090087097 · DOI
Mangiola M, 2003, Leuk Lymphoma, 44, S4
10.1182/blood.V98.10.3050 · DOI
10.1046/j.1365-2141.1996.00305.x · DOI · Paper page
10.1182/blood.V99.3.1030 · DOI · Paper page
10.1182/blood-2003-03-0989 · DOI
10.1182/blood.V97.9.2777 · DOI
Chen H, 2000, Blood, 96, 3181, 10.1182/blood.V96.9.3181 · DOI
10.1182/blood-2003-08-2763 · DOI
10.1080/10428190290011921 · DOI
10.1182/blood-2002-04-1174 · DOI
10.1016/S0065-230X(00)79005-1 · DOI
10.1182/blood-2001-11-0066 · DOI
Schiffer LM, 1969, Br J Haematol, 17, 408
Theml H, 1973, Blood, 42, 623, 10.1182/blood.V42.4.623.623 · DOI
10.1038/sj.bjc.6600763 · DOI
10.1182/blood-2003-04-1345 · DOI
10.1073/pnas.022604399 · DOI
10.1016/S0161-5890(01)00025-6 · DOI
10.1126/science.286.5447.2156 · DOI
10.1084/jem.190.10.1405 · DOI
10.1172/JCI113620 · DOI
10.1006/jaut.1993.1066 · DOI
Pugh-Bernard AE, 2001, J Clin Invest, 108, 1061, 10.1172/JCI200112462 · DOI
10.1182/blood.V100.2.635 · DOI
10.1182/blood-2003-09-3277 · DOI
10.1182/blood-2002-03-0892 · DOI
10.1182/blood.V99.11.4087 · DOI
10.1016/S0952-7915(00)00204-1 · DOI
10.1084/jem.20031550 · DOI
10.1016/S1471-4906(03)00119-4 · DOI

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
Byrd, J. C., Furman, R. R., Coutre, S. E., Flinn, I. W., Burger, J. A., Blum, K. A., Grant, B., Sharman, J. P., Coleman, M., Wierda, W. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215637 · Cited by 2,270
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Woyach, J. A., Furman, R. R., Liu, T.-M., Ozer, H. G., Zapatka, M., Ruppert, A. S., Xue, L., Li, D. H.-H., Steggerda, S. M., Versele, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400029 · Cited by 1,275
ZAP-70: an essential kinase in T-cell signaling
Wang, H., Kadlecek, T. A., Au-Yeung, B. B., Goodfellow, H. E. S., Hsu, L. Y., Freedman, T. S., & Weiss, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002279 · Cited by 395

See all 1,296

Authors: Chiorazzi, N., Rai, K. R., & Ferrarini, M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-02-24
Volume: 352
Issue: 8
Pages: 804-815
ISSN: 0028-4793
1533-4406
DOI: 10.1056/nejmra041720
Cited by: 1,296
References: 0
Language: en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page: CoChat. (2026). Citation check: Chronic lymphocytic leukemia. https://app.cochat.ai/papers/10.1056/nejmra041720
The paper: Chiorazzi, N., Rai, K. R., & Ferrarini, M. (2005). Chronic lymphocytic leukemia. New England Journal of Medicine. https://doi.org/10.1056/nejmra041720

Chronic lymphocytic leukemia.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks

How to cite